Hawaiian Cancer Warriors Lead Research In Pacific

A university facility looks for tropical medicines while its epidemiology program tries to link disease and lifestyle HONOLULU -- An organism that Hawaiians call limu-make-o-hana thrives in the tide pools near the town of Hana, on the island of Maui, according to University of Hawaii chemist Richard Moore. And when Hawaiian warriors of the past, in search of a lethal poison, placed an exudate of this organism on their spear tips, they were on the right track, says Moore. Palytoxin is the exud

Written byPaul Mccarthy
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


A university facility looks for tropical medicines while its epidemiology program tries to link disease and lifestyle
HONOLULU -- An organism that Hawaiians call limu-make-o-hana thrives in the tide pools near the town of Hana, on the island of Maui, according to University of Hawaii chemist Richard Moore. And when Hawaiian warriors of the past, in search of a lethal poison, placed an exudate of this organism on their spear tips, they were on the right track, says Moore.

Palytoxin is the exudate of the limu-make-o-hana (in Hawaiian, "the deadly seaweed of Hana," a misnomer since it is a sea anemone-like organism and not a seaweed). It is one of the most deadly cytotoxins known to man. One day, thanks to the efforts of Moore and colleagues at the Cancer Research Center of Hawaii (CRCH), palytoxin may be mounted on antibodies instead of spears for use as an immunotoxin in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies